Search

everythinglearnresearchcommunity

for

Search:↓

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

Neurosteroids help control dopamine responses in the brain.

Blocking prolactin increases the activity of secondary hair follicles in cashmere goats.

Alfuzosin reduces short-term surgery need after catheter removal, but long-term benefits are unclear; combination therapy may help prevent urinary issues.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Allopregnanolone can reduce gut inflammation and normalize neurotransmitter levels after finasteride withdrawal.

A new peptide, FOL-005, may help treat excessive hair growth by reducing a hair growth promoter, FGF7.

5-Alpha reductase inhibitors help treat enlarged prostate but may cause sexual side effects.

Neurosteroids can influence behavior by modulating brain inhibition, with potential for treating psychiatric disorders.

Current treatments for postmenopausal frontal fibrosing alopecia stop hair loss but don't regrow hair.

Goserelin injections can effectively manage hyperandrogenism symptoms in postmenopausal women who can't have surgery.

Intralesional triamcinolone acetonide helps regrow eyebrows in patients with frontal fibrosing alopecia.

Tamsulosin is a cost-effective treatment for BPH symptoms.

Paeoniflorin protects brain cells by involving a specific protein and neurosteroids.

Certain substances can decrease or increase exploratory behavior in rodents.

Early combination therapy can effectively regrow hair in frontal fibrosing alopecia.

FOL-026 peptide can help repair blood vessels and promote growth, offering potential treatment for vascular diseases.

5αR inhibitors help slow early prostate cancer cell growth, suggesting combined treatments are needed.

Finasteride before TURP reduces blood loss and improves early postoperative quality of life.

Tafluprost could be a potential treatment for hair loss by promoting hair growth phase changes.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Cabergoline is more effective and has fewer side effects than bromocriptine for treating women with hyperprolactinemic amenorrhea.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

Delta-opioid receptors affect skin cell circadian rhythms, possibly impacting wound healing and cancer.

The study suggests hormonal factors may play a role in Frontal Fibrosing Alopecia and that treatments like oral antiandrogens and steroids could be beneficial.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.